Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience


Creative Commons License

KORKMAZ P. , Caglan F. C. , Aykin N., NAZ H., TOKA O.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.22, ss.92-96, 2016 (ESCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 22 Konu: 3
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4274/vhd.94830
  • Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Sayfa Sayıları: ss.92-96

Özet

Objective: The aim of the study was to evaluate the long-term results of treatment efficacy and safety in nucleos(t)ide analogue-naive (NA-naive) and NA-experienced chronic hepatitis B (CHB) patients receiving tenofovir disoproxil fumarate (TDF) therapy.